Anna C. Gebhard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna C. Gebhard has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia V. Riazanova
Department of Fibre and Polymer Technology, KTH Royal Institute of Technology , Teknikringen 56-58, Stockholm 10044
1 shared publication Anna J. Svagan
1 shared publication- Anna Justina Svagan
KTH Royal Institute of Technology
1 shared publication Anran Mao
1 shared publication- Anran Mao
Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, Teknikringen 56, 100 44 Stockholm, Sweden
1 shared publication Anton A.A. Autzen
1 shared publication
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in Carbohydrate Polymer Technologies and Applications
- Vol. 16
Hydrophobic small-molecule loading and cellulase-responsive degradation in lyophilized cellulose nanofiber/pectin Pickering microcapsules
- 24 September 2026
- Published by Elsevier in Carbohydrate Polymer Technologies and Applications
- Vol. 16
Open AccessHydrophobic small-molecule loading and cellulase-responsive degradation in lyophilized cellulose nanofiber/pectin Pickering microcapsules
- Open Access
- 16 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (20)
Plant cell–inspired colon-targeted cargo delivery systems with dual-triggered release mechanisms
Plant cells represent smart cargo carriers with great socioeconomic potential in oral drug delivery applications. The two exterior barriers, featuring a rigid cell wall and a dense plasma membrane, are unique with complementary structural, mechanical, and chemical properties. Current strategies for producing therapeutic drugs within plant cells for oral delivery are efficient, but largely limited to recombinant pharmaceutical proteins, and involve complex genetic modification of plants. To address this, we engineer plant cell–inspired delivery systems with cellulose nanofiber–based shells and lipid layers through a bottom-up assembly strategy, which offers greater flexibility to encapsulate nonprotein compounds and nanoparticles. Notably, the layered shell structure resists degradation in acidic environments, and two barriers respond differently to external stimuli in simulated gastrointestinal medium, resulting in size-dependent dual-triggered release mechanisms. The cytocompatibility was shown by incubation with Caco-2 cells. Our results open avenues for developing next generation of bioinspired oral delivery systems for multisite-specific gastrointestinal release in a low-cost and sustainable manner.
- 16 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (20)
Open AccessPlant cell–inspired colon-targeted cargo delivery systems with dual-triggered release mechanisms
Plant cells represent smart cargo carriers with great socioeconomic potential in oral drug delivery applications. The two exterior barriers, featuring a rigid cell wall and a dense plasma membrane, are unique with complementary structural, mechanical, and chemical properties. Current strategies for producing therapeutic drugs within plant cells for oral delivery are efficient, but largely limited to recombinant pharmaceutical proteins, and involve complex genetic modification of plants. To address this, we engineer plant cell–inspired delivery systems with cellulose nanofiber–based shells and lipid layers through a bottom-up assembly strategy, which offers greater flexibility to encapsulate nonprotein compounds and nanoparticles. Notably, the layered shell structure resists degradation in acidic environments, and two barriers respond differently to external stimuli in simulated gastrointestinal medium, resulting in size-dependent dual-triggered release mechanisms. The cytocompatibility was shown by incubation with Caco-2 cells. Our results open avenues for developing next generation of bioinspired oral delivery systems for multisite-specific gastrointestinal release in a low-cost and sustainable manner.